Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Prokidney (PROK) Shares Outstanding: 2022-2025

Historic Shares Outstanding for Prokidney (PROK) over the last 4 years, with Sep 2025 value amounting to $159.3 million.

  • Prokidney's Shares Outstanding fell 2.72% to $159.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.3 million, marking a year-over-year decrease of 2.72%. This contributed to the annual value of $163.7 million for FY2024, which is 2.74% down from last year.
  • As of Q3 2025, Prokidney's Shares Outstanding stood at $159.3 million, which was down 0.00% from $159.3 million recorded in Q2 2025.
  • In the past 5 years, Prokidney's Shares Outstanding registered a high of $186.5 million during Q1 2022, and its lowest value of $159.3 million during Q2 2025.
  • Moreover, its 3-year median value for Shares Outstanding was $163.8 million (2024), whereas its average is $166.4 million.
  • Over the last 5 years, Prokidney's Shares Outstanding had its largest YoY gain of 1.54% in 2023, and its largest YoY loss of 7.00% in 2023.
  • Prokidney's Shares Outstanding (Quarterly) stood at $171.6 million in 2022, then fell by 1.91% to $168.3 million in 2023, then decreased by 2.74% to $163.7 million in 2024, then declined by 2.72% to $159.3 million in 2025.
  • Its last three reported values are $159.3 million in Q3 2025, $159.3 million for Q2 2025, and $163.2 million during Q1 2025.